
5MG
Retatrutide
Triple-agonist for body composition
Retatrutide is an investigational triple-agonist peptide engineered for body composition research with a long half-life suitable for weekly administration.
How it works
Acts simultaneously on GLP-1, GIP and glucagon receptors, addressing metabolism, satiety and energy expenditure in parallel.
What to expect
Appetite drops noticeably in the first 1 to 3 weeks. Steady fat loss continues across months 2 to 6, with visible changes in waist and body fat by month 4. Most users report reduced cravings, easier portion control and consistent weekly progress on the scale.
Body Composition
Supports significant changes in weight and adiposity.
Appetite Regulation
Modulates satiety signaling for sustained control.
Metabolic Efficiency
Targets GLP-1, GIP and glucagon receptors.
Energy Expenditure
Increases resting energy use via glucagon activity.
$67.00
View & Buy














